Targeted metabolomics of CSF in healthy individuals and patients with secondary progressive multiple sclerosis using high-resolution mass spectrometry
Henrik Carlsson(Uppsala University Hospital), Kim Kultima(Uppsala University), Sandy Abujrais(Uppsala University Hospital), Payam Emami Khoonsari(Stockholm University), Torbjörn Åkerfeldt(Uppsala University), Joachim Burman(Uppsala University), Stephanie Herman(Uppsala University), Anders Svenningsson(Karolinska Institutet)
Cited by 34
Related Papers
Axonal damage in relapsing multiple sclerosis is markedly reduced by natalizumab
|Annals of Neurology|2010|347
Faced with inequality: chicken do not have a general dosage compensation of sex-linked genes
|BMC Biology|2007|257
Neurofilament and glial fibrillary acidic protein in multiple sclerosis
|Neurology|2004|245
Treatment Escalation vs Immediate Initiation of Highly Effective Treatment for Patients With Relapsing-Remitting Multiple Sclerosis
|JAMA Neurology|2021|237
PhenoMeNal: processing and analysis of metabolomics data in the cloud
|GigaScience|2018|147